Development of Receptor Binding Domain (RBD)‐Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS‐CoV‐2 Delta and Other Variants

The SARS‐CoV‐2 Delta (B.1.617.2) strain is a variant of concern (VOC) that has become the dominant strain worldwide in 2021. Its transmission capacity is approximately twice that of the original strain, with a shorter incubation period and higher viral load during infection. Importantly, the breakth...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ran, Zhang, Xiantao, Yuan, Yaochang, Deng, Xiaohui, Wu, Bolin, Xi, Zhihui, Wang, Guanwen, Lin, Yingtong, Li, Rong, Wang, Xuemei, Zou, Fan, Liang, Liting, Yan, Haiping, Liang, Chaofeng, Li, Yuzhuang, Wu, Shijian, Deng, Jieyi, Zhou, Mo, Zhang, Xu, Li, Congrong, Bu, Xiuqing, Peng, Yi, Ke, Changwen, Deng, Kai, He, Xin, Zhang, Yiwen, Zhang, Zhenhai, Pan, Ting, Zhang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008796/
https://www.ncbi.nlm.nih.gov/pubmed/35142444
http://dx.doi.org/10.1002/advs.202105378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008796/
https://www.ncbi.nlm.nih.gov/pubmed/35142444
http://dx.doi.org/10.1002/advs.202105378

Ejemplares similares